Variation in neurocognitive and psychological symptoms between children and adults treated with elexacaftor/tezacaftor/ivacaftor (ETI)

被引：0
|
作者：
Barker, Jessica [1 ]
Krishan, Smriti [1 ]
Thomsen, Amanda [1 ]
Owens, Louisa [1 ,2 ]
Prentice, Bernadette [1 ,2 ]
机构：
[1] Sydney Childrens Hosp, Sydney, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
103
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [21] Elexacaftor/Tezacaftor/Ivacaftor (ETI) Treatment Corrects the Salt-Losing Phenotype in People with Cystic Fibrosis
    Leipziger, Jens G.
    Svendsen, Samuel L. C.
    Rousing, Amalie Quist
    Bandulik, Sascha
    Warth, Richard
    Sorensen, Mads Vaarby
    Jeppesen, Majbritt
    Berg, Peder
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [22] Exercise tolerance in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor
    Hrvoic, Lovro
    Bambir, Ivan
    Omerza, Lana
    Todoric, Ivana
    Markelic, Ivona
    Dugac, Andrea Vukic
    Tjesic-Drinkovic, Duska
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [23] Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
    Reasoner, Seth A.
    Bernard, Rachel
    Waalkes, Adam
    Penewit, Kelsi
    Lewis, Janessa
    Sokolow, Andrew G.
    Brown, Rebekah F.
    Edwards, Kathryn M.
    Salipante, Stephen J.
    Hadjifrangiskou, Maria
    Nicholson, Maribeth R.
    MBIO, 2024, 15 (02):
  • [24] Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor
    Stastna, Nela
    Kunovsky, Lumir
    Svoboda, Michal
    Pokojova, Eva
    Homola, Lukas
    Mala, Miriam
    Gracova, Zaneta
    Jerabkova, Barbora
    Skrickova, Jana
    Trna, Jan
    DIGESTIVE DISEASES, 2024, 42 (04) : 361 - 368
  • [25] Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor
    Wood, Marci
    Babowicz, Faith
    Kennedy, Amanda G.
    Antell, Martine
    Gilhooly, Elizabeth
    Tompkins, Bradley J.
    Reddy, Sheela S.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (03) : 920 - 924
  • [26] Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis
    Royo, Rosa Nieto
    Barata, Diego Duran
    Barreto, Deisy Barrios
    Franquiz, Winnifer Briceno
    Carro, Luis Maiz
    MEDICINA CLINICA, 2023, 161 (08): : 338 - 341
  • [27] ELEXACAFTOR-IVACAFTOR-TEZACAFTOR IMPROVES CHRONIC RHINOSINUSITIS SYMPTOMS IN CYSTIC FIBROSIS
    Stapleton, A. M.
    Kimple, A. J.
    Goralski, J. L.
    Nouraie, M.
    Shaffer, A.
    Pilewski, J. M.
    Senior, B. A.
    Lee, S.
    Zemke, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S292 - S292
  • [28] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ALTERS GASTROINTESTINAL SYMPTOMS AND INFLAMMATION: REPORT OF PROMISE GI
    Schwarzenberg, S.
    Vu, P.
    Khan, U.
    Freedman, S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S123 - S123
  • [29] Analysis of systemic Chemokines in Adults with CF receiving Elexacaftor/Tezacaftor/Ivacaftor Therapy
    Pipping, J.
    Westhoelter, D.
    Raspe, J.
    Schmitz, M.
    Strassburg, S.
    Sutharsan, S.
    Welsner, M.
    Taube, C.
    Reuter, S.
    PNEUMOLOGIE, 2023, 77 : S92 - S92
  • [30] Gastroesophageal reflux burden in youth with CF treated with elexacaftor-tezacaftor-ivacaftor
    Bass, Rosara
    Mascarenhas, Maria
    Kelly, Andrea
    Mousa, Hayat
    PEDIATRIC PULMONOLOGY, 2023, 58 (12) : 3637 - 3640
12345